Shareholding disclosure

Kuros Biosciences AG

Declared position

23.2%

Threshold

Crossed downwards

Timeline

Published

31.01.2017

Transaction

27.01.2017

Voting rights breakdown

Voting rights acquired0.1%
Voting rights sold23.2%
Below threshold0%

Notice details

CategorySingle shareholder
ExchangeXSWX

Notification ID

TAH1U00019

Beneficial owner

Kuros Biosciences AG

Declared address

Kuros Biosciences AG, 8952 Schlieren

Conditional Obligation to issue new shares pursuant to a Combination Agreement entered with shareholders of Xpand Biotechnology BV on 18 December 2016: 1'365'000 shares of Kuros Biosciences Ltd have been issued and transferred at closing of the Combination Agreement and 740'000 shares of Kuros Biosciences Ltd to be issued at the achievement of certain product approval milestones.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open